S. Korea's Celltrion says top shareholder drops plan to sell stake
SEOUL, July 2
SEOUL, July 2 (Reuters) - Celltrion Inc said on Wednesday its top shareholder is no longer considering a sale of a stake in the biotechnology company.
Founder and Chief Executive Seo Jung-jin last year said he would seek a buyer among multinational drugmakers for his controlling interest in the company.
Celltrion is the largest stock on South Korea's junior bourse with a market value of 4.87 trillion won ($4.83 billion) as of Wednesday's close.
($1 = 1009.1000 South Korean Won) (Reporting by Joyce Lee; Editing by Christopher Cushing)
- U.S. man sues soccer star Cristiano Ronaldo over CR7 trademark
- Moscow fights back after sanctions; battle rages near Ukraine crash site |
- Netanyahu vows to complete Gaza tunnels destruction
- Argentina defaults but investors see eventual deal possible
- Obama to Republicans: ‘Stop just hatin’ all the time’